Releases


All 2014 Releases
Apr 9, 2014 Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting  
Apr 9, 2014 Veloxis Pharmaceuticals A/S - Forløb af ordinær generalforsamling  
Mar 25, 2014 Warrantordning - Nye vedtægter  
Mar 25, 2014 Warrant Programme - New Articles of Association  
Mar 20, 2014 Warrant Programme - Registration of capital increase and new Articles of Association following warrant exercise  
Mar 20, 2014 Warrant Program - Registrering af kapitalforhøjelse og nye selskabsvedtægter i forlængelse af warrantudnyttelse  
Mar 20, 2014 Warrantprogram - Veloxis Pharmaceuticals A/S udsteder nye aktier i forbindelse med udnyttelse af warrants og indberetning af aktietransaktioner af nuværende og tidligere medarbejdere i Veloxis Pharmaceuticals A/S  
Mar 20, 2014 Warrant Programme - Veloxis Pharmaceuticals A/S issues new shares in connection with exercise of warrants and announces trading in the company's shares by current and former employees  
Mar 17, 2014 Indkaldelse til ordinær generalforsamling  
Mar 17, 2014 Notice to Convene Annual General Meeting  
Mar 14, 2014 Korrektion: Den amerikanske lægemiddelmyndighed FDA accepterer Veloxis' registreringsansøgning (New Drug Application) for Envarsus® til forebyggelse af organafstødning i nyretransplantationspatienter  
Mar 14, 2014 Correction: U.S. FDA Accepts Veloxis' New Drug Application for Envarsus® for the Prevention of Organ Rejection in Kidney Transplant Patients  
Mar 14, 2014 Veloxis Pharmaceuticals A/S etablerer warrantordning  
Mar 14, 2014 Veloxis Pharmaceuticals A/S establishes new Warrant Programme  
Mar 13, 2014 U.S. FDA Accepts Veloxis' New Drug Application for Envarsus® for the Prevention of Organ Rejection in Kidney Transplant Patients  
Mar 13, 2014 Den amerikanske lægemiddelmyndighed FDA accepterer Veloxis' registreringsansøgning (New Drug Application) for Envarsus® til forebyggelse af organafstødning i nyretransplantationspatienter  
Mar 6, 2014 Veloxis Promotes John Weinberg to Chief Operating Officer  
Mar 6, 2014 Veloxis forfremmer John Weinberg til Chief Operating Officer  
Mar 5, 2014 Veloxis Pharmaceuticals publishes Annual Report 2013  
Mar 5, 2014 Veloxis Pharmaceuticals offentliggør årsrapport 2013  
Mar 3, 2014 Veloxis Pharmaceuticals A/S er vært for en telekonference i forbindelse med offentliggørelsen af årsrapporten 2013 — resultater fra 1. januar til 31. december 2013  
Mar 3, 2014 Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Annual report 2013 — results from 1 January to 31 December, 2013  
Jan 8, 2014 Veloxis Pharmaceuticals modtager patentgodkendelse fra den amerikanske patentmyndighed på indgivelse af Envarsus® uafhængig af tidspunkt på døgnet  
Jan 8, 2014 Veloxis Pharmaceuticals Receives Notice of Allowance from U.S. Patent Office for Diurnal-Independent Administration of Envarsus®  
Showing 1-24 of 24 Page: 1  
=add release to Briefcase